At that time, only data points from 2000 through 2011 were available, and reliable predictions could only be made through 2015. Lack of data on endovascular aneurysm repair (EVAR) using fenestrated (FEVAR) and branched (BrEVAR) endografts also affected our findings. Despite these limitations, our predictions for OAR completed by vascular trainees were accurate for 2012 to 2014. This report uses updated data points through 2014 in conjunction with data on FEVAR and BrEVAR obtained from industry to predict trends in OAR and how it will affect vascular surgery training through 2020.
The use of endovascular abdominal aortic aneurysm (AAA) repair (EVAR) in recent years has transformed the paradigm of surgical management of AAAs. Epidemiologic evidence shows improved short-term mortality and reduced short-term hospital length of stay when EVAR is compared with open AAA repair (OAR) in the perioperative period. [1] [2] [3] [4] Reduced perioperative mortality has also been seen in elective patients with moderate-risk to high-risk comorbidities in a Medicare risk-prediction model. 5 Implementation of EVAR has further contributed to a reduction in total deaths associated with intact and ruptured AAA, including a decreased requirement for ruptured repairs. 5 Such data have justified the progressive increase in the proportion of EVARs performed each year for AAAs. From 2000 to 2010, the proportion of EVARs used in total AAA repairs rose from 5.2% to 74%. Despite this rise, the total number of patients presenting for AAA repair (ruptured and unruptured) has remained constant at 45,000. There is concern that the number of OARs performed may be insufficient for the Accreditation Council for Graduate Medical Education (ACGME) graduation requirement of Some have suggested that OAR numbers will continue to see further decline because fenestrated (FEVAR) and branched (BrEVAR) endograft techniques are also being used to achieve greater anatomical compliance in AAA repair.
1,2,9 FEVAR and BrEVAR implementation has shown reduced perioperative respiratory complications compared with OAR. 10 Despite a high degree of procedural difficulty, FEVAR and BrEVAR have also been beneficial for juxtarenal and thoracoabdominal aortic aneurysm repair after previous EVAR or OAR, including patients considered high risk.
11
Through previous work, we estimated reliable predictions for OAR numbers at teaching hospitals through 2015 based on the National Inpatient Sample (NIS), State Inpatient Databases, and ACGME case log data from 2000 to 2011.
1,2 Regression estimates through 2012 to 2014 have proven to be accurate. Future predictions, however, have been limited because of a lack of data on FEVAR and BrEVAR endograft implementation. Therefore, in this study, we examined updated data points through 2014 and included industry numbers on FEVAR and BrEVAR to provide increasingly accurate predictions for the amount of available OARs for vascular surgery trainees through 2020.
METHODS
Database and selection. A retrospective analysis was completed using the NIS, a part of the Health Care Utilization Project that is maintained by the Agency for Healthcare Research and Quality. The NIS is the largest all-payer inpatient database and includes a stratified 20% random sample of all nonfederal inpatient hospital admissions throughout the United States. Clinical records were derived using the Ninth Revision of the International Classification of Diseases diagnosis and procedure codes to ensure that the sample included patients who underwent treatment primarily for AAA. This study was exempt from Institutional Review Board approval given the deidentified nature of the data via a large database. Patient consent was not required.
"Open aneurysm" included infrarenal AAA, juxtarenal AAA, pararenal AAA, and suprarenal AAA. Variables included the year and procedure performed. An S-curve modified logistic function was used to model the effect of introducing new technologies (EVAR, FEVAR, BrEVAR) on the standard management of AAA with OAR starting in the year 2000, similar to the technique that we have previously described. 2 New technologies undergo predictable growth over time that can be modeled using S-curve logistic regressions. S-curve modified logistic regression is best suited for modeling systems in which new technology is adopted and the rate of initial adoption is slow until some critical mass (ie, sufficiently trained physicians) is reached. Adoption is then fast until a saturation point is reached (ie, patients not candidates for EVAR). Weighted samples and data from the United States Census Bureau were used in conjunction with volume estimates derived from the NIS, State Inpatient Databases, and industry sources to determine trends in OAR and EVAR. Specifically, the State Inpatient Database was used to confirm the numbers acquired from the Current Procedural Terminology (American Medical Association, Chicago, Ill) codes within the NIS. From the ACGME, the mean number of cases done for AAA repair was documented. Finally, industry (Cook Medical, Bloomington, Ind) provided the FEVAR and BrEVAR figures. The number of cases completed at teaching hospitals was calculated using the NIS, and ACGME case logs and used to forecast the number of cases completed by vascular surgery trainees through 2020 (prediction modeling). Sensitivity analysis and trend analysis were completed.
RESULTS
Approximately 45,000 AAA repairs are completed annually in the United States, but only 15% of these are now completed using OAR compared with >50% just a decade ago (Fig) . Further, with the accelerating adoption of FEVAR and BrEVAR and expanding indications for standard EVAR, our model predicts that <3000 OAR will be completed annually by 2020 (Table) . Because only a subset of these cases are completed at teaching institutions, our model predicts that a vascular surgery trainee in a fellowship program will complete only one to two OARs, whereas trainees in a 0þ5 program may complete two to three OARs (Fig; Table) .
DISCUSSION
EVAR continues to rise in proportion to OAR in AAA repair given favorable perioperative outcomes and reduced hospital length of stay, among other benefits. 1 As EVAR has gained favor, the proportion of OARs dropped from 95% of the total case load in 2000 to just 20% in 2012. Despite the acknowledged rise of EVAR and the recent advent of FEVAR and BrEVAR graft techniques, AAA repairs have remained constant at 45,000.
The decline in the number of OARs performed each year has resulted in significant apprehension within the vascular community given an associated link between institutional and individual surgeon case volume and the mortality rate of OAR. 12, 13 Data from ACGME case logs show that 5þ2 and 0þ5 program vascular residents logged an average of 12.4 and 11.3 OARs, respectively, from 2014 to 2015 (averages added for unruptured and ruptured cases for both programs as well as chief and junior cases in the 0þ5 program). In the present study, our goal was to establish a predictive model for the effect of endovascular innovation on the average number of OARs performed by vascular surgery trainees. Using S-curved modified logistic regression to account for the direction of endovascular technology (including EVAR, FEVAR, and BrEVAR), vascular trainees will complete an average of only one to three OARs by 2020. In comparison, previous predictions had suggested each vascular trainee would complete approximately five OARs by this time. We attribute this discrepancy to the recent inclusion of FEVAR and BrEVAR into practice. Through literature review, the use of FEVAR and BrEVAR technologies in teaching hospitals increased from 469 cases in 2011 to 2131 cases in 2012. These approaches are gaining favor in specific cases for their anatomical compliance, potential benefit in thoracoabdominal and juxtarenal AAA repair, and application in patients with significant comorbidities at high surgical risk when being considered for OAR.
14 Although 0þ5 programs have seen a 24% greater volume of total endovascular procedures, no difference in the average OAR or EVAR case volume between 0þ5 and 5þ2 vascular programs was reported from 2010 to 2013. 15 How future trends in OAR will affect separate programs remains unclear, however. Addressing the issue of declining OAR numbers in vascular teaching platforms has led to innovation of possible methods for increasing resident exposure and experience. In our previous work, we suggested the potential benefit of simulation approaches. In 2013, vascular trainee survey responses indicated that 56% of vascular training institutions offer simulation-based training. 16 Training methods, however, are primarily limited because of disintegrated implementation and lack of standardization. 17, 18 Life-like pulsatile-flow models are being developed. 19 Well-defined, standardized expectations for implementation of OAR simulation techniques may prove to be a vital for ensuring proper vascular training.
Regionalization of care to specialized, high-volume centers has been discussed as another potential option for addressing the progressive shortfall of OARs. This principle has generated much controversy, given potential implications for patient burden and dichotomy of vascular practice strategy. 20 Evidence has shown, however, that procedure volume is associated with mortality benefit in OARs. Implementation of high-volume approach Leapfrog standards for evidence-based referral showed an estimated reduction in elective AAA repairs. 12, 21 Mortality in AAAs has further been examined in the comparison of OAR to EVAR between variables of institutional and physician volume. Although no difference in mortality for volume levels was observed in EVARs, a significant reduction occurred in mortality with institutional volume and, particularly, individual physician volume in OARs. 7 Interestingly, composite surgeon procedure volume (the sum of several open vascular operations) has also been shown to benefit mortality rates for OAR. 8 These findings justify further investigation toward an approach for regionalizing OARs based on considerations for institution and physician volume. This study is limited by its retrospective design and its use of large databases that are collected using Ninth Revision of the International Classification of Diseases codes. Hence, the number of open AAA may be underrepresented. Furthermore, the use of ACGME case logs to determine trainee numbers may also be partially flawed because various procedures may be coded differently by different trainees. We were unable to include data from the federal system (Veterans Affairs) because that was not available. Finally, the prediction modeling does not take into account new or emerging technology that may decrease further the number of OAR cases for trainees.
CONCLUSIONS
Our initial prediction in the 2014 report was that vascular trainees will complete approximately five OARs by 2020. After incorporating new data on BrEVAR, FEVAR, and the accelerating pace of EVAR use between 2012 and 2014, it now appears that vascular trainees will complete one to three OARs during their training. This is lower than the five OAR cases recommended to achieve minimum performance standards per hospital. 9 Expanded use of surgical simulation, external rotations, increasing access to AAA cases at nonteaching hospitals, and changes in public policy leading to the establishment of regional centers of excellence all merit consideration to offset the shortfall in training expected within the next few years. Further studies will be needed to assess the effect on patient outcomes of this decreasing OAR experience for trainees.
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Regardless of the ultimate solution, vascular surgeons will be forced to examine current training paradigms, accepting that it will be necessary to change long standing models, now outdated because of new technology and endovascular approaches. Mills 2 has suggested that what we really want to measure is competence, and until now, volume has been a surrogate for competence. Although there is currently no single, good simulation of the OAR, vascular surgeons have long held that the techniques learned from open vascular surgery
